Watson Pharmaceuticals Inc. (NYSE:WPI) recently announced the filing of an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) for a generic version of Depomed Inc.’s (NASDAQ:DEPO) diabetes drug, Glumetza. The drug is used as an adjunct to diet and exercise to improve glycemic control in adults with type II diabetes.
In response, Depomed and Valeant International together filed a lawsuit against Watson Pharma in the United States District Court for the District of … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards